SIGNATURE BIOSCIENCE
Signature BioScience Inc. was the first biotechnology company based in San Francisco. It was formed in 1998 but closed in 2003 due to lack of funding. Before Signature was dissolved, it had just completed Phase II trials on Digitoxin, which the company was pursuing as an anti-cancer compound. However, the company's core competency was developing biotechnology tools that would be used to identify highly qualified pre-clinical leads.
SIGNATURE BIOSCIENCE
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1998-01-01
Address:
Hayward, California, United States
Country:
United States
Total Employee:
101+
Status:
Active
Total Funding:
58.96 M USD
Similar Organizations
NeoGenesis Pharmaceuticals
A drug discovery company which uses it proprietary affinity-based screening technologies and integrated chemical library
Quanta BioDesign
The Quanta BioDesign dPEG® product line is a unique technology platform.
Founder
Investors List
Prospect Venture Partners
Prospect Venture Partners investment in Series E - Signature BioScience
Shelter Growth Capital Partners
Shelter Growth Capital Partners investment in Series E - Signature BioScience
Atlas Venture
Atlas Venture investment in Series E - Signature BioScience
Coral Ventures
Coral Ventures investment in Series E - Signature BioScience
Abingworth
Abingworth investment in Series E - Signature BioScience
Shelter Growth Capital Partners
Shelter Growth Capital Partners investment in Series D - Signature BioScience